Physician profile
Ebrahim Duel
NPI 1659386027
$1,330.27
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $281 · 2021: $98.02 · 2022: $91.80 · 2023: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $930.24 | 2019-2023 | Lo Loestrin Fe |
| Ethicon US, LLC | $92.85 | 2019-2020 | |
| Roche Diagnostics Corporation | $72.02 | 2020-2021 | |
| Hologic Sales and Service, LLC | $57.18 | 2019-2023 | Aptima |
| Organon LLC | $43.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.80 | 2023 | |
| Allergan, INC. | $24.05 | 2019 | |
| Mayne Pharma Commercial LLC | $23.46 | 2021 | |
| Shield Therapeutics INC | $19.37 | 2023 | Accrufer |
| Pfizer INC. | $17.44 | 2022 | |
| Novo Nordisk INC | $16.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebrahim Duel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.